By Elias Schisgall
Shares of 908 Devices slipped after the maker of chemical-analysis devices reported a wider-than-expected loss and lower revenue.
The stock fell 11%, to $6.55 a share, midday Monday, but has nearly tripled year-to-date.
The company posted a third-quarter loss of $15 million, or 41 cents a share, compared with a loss of $29.3 million, or 84 cents a share, a year earlier.
Analysts surveyed by FactSet expected a loss of about 14 cents a share.
The Boston company reported $14 million in revenue, a 4% decrease from the year before.
It said it continues to expect full-year revenue between $54 million and $56 million. Analysts are expecting $55.4 million.
Write to Elias Schisgall at elias.schisgall@wsj.com
(END) Dow Jones Newswires
November 10, 2025 15:10 ET (20:10 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
Comments